含硫代氨基脲配体的有机金属钌配合物：[(η-对异丙基苯)钌(NS)Cl]（NS = 9-蒽甲醛硫代氨基脲）的合成、结构及细胞毒性
Organometallic ruthenium complexes with thiosemicarbazone ligands: Synthesis, structure and cytotoxicity of [(eta-p-cymene)Ru(NS)Cl] (NS = 9-anthraldehyde thiosemicarbazones).
作者信息
Beckford Floyd A, Leblanc Gabriel, Thessing Jeffrey, Shaloski Michael, Frost Brian J, Li Liya, Seeram Navindra P
机构信息
Science Division, Lyon College, Batesville, AR 72501, USA.
出版信息
Inorg Chem Commun. 2009 Nov 1;12(11):1094-1098. doi: 10.1016/j.inoche.2009.08.034.
Abstract
A series of half-sandwich arene-ruthenium complexes of the type (eta(6)-p-cymene) Ru(thiosemicarbazone)Cl have been synthesized and their biological activity investigated. The first structurally characterized arene-ruthenium half-sandwich complex with a thiosemicarbazone ligand is reported.
摘要
已合成了一系列(η(6)-对异丙基苯)Ru(硫代半卡巴腙)Cl型的半夹心芳烃-钌配合物，并对其生物活性进行了研究。报道了首个具有硫代半卡巴腙配体的经结构表征的芳烃-钌半夹心配合物。
相似文献
1
Organometallic ruthenium complexes with thiosemicarbazone ligands: Synthesis, structure and cytotoxicity of [(eta-p-cymene)Ru(NS)Cl] (NS = 9-anthraldehyde thiosemicarbazones).含硫代氨基脲配体的有机金属钌配合物：[(η-对异丙基苯)钌(NS)Cl]（NS = 9-蒽甲醛硫代氨基脲）的合成、结构及细胞毒性
Inorg Chem Commun. 2009 Nov 1;12(11):1094-1098. doi: 10.1016/j.inoche.2009.08.034.
2
Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.含噻唑烷酮的钌-芳配合物的半夹心配合物：[(η⁶-p-枯茗烯)Ru(胡椒醛缩噻唑烷酮)Cl]Cl 配合物的合成与生物评价。
J Inorg Biochem. 2011 Aug;105(8):1019-29. doi: 10.1016/j.jinorgbio.2011.04.008.
3
Solution equilibrium, structural and cytotoxicity studies on Ru(η-p-cymene) and copper complexes of pyrazolyl thiosemicarbazones.对 Ru(η-p-cymene)和吡唑基硫代缩氨基脲铜配合物的溶液平衡、结构和细胞毒性研究。
J Inorg Biochem. 2020 Jan;202:110883. doi: 10.1016/j.jinorgbio.2019.110883. Epub 2019 Oct 22.
4
Half-sandwich Ru(η-p-cymene) complexes featuring pyrazole appended ligands: Synthesis, DNA binding and in vitro cytotoxicity.含吡唑取代配体的半三明治 Ru(η-p-cymene)配合物的合成、DNA 结合及体外细胞毒性。
J Inorg Biochem. 2019 May;194:74-84. doi: 10.1016/j.jinorgbio.2019.02.012. Epub 2019 Feb 23.
5
Ruthenium -Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties.钌-苎烯配合物，引入取代吡啶-喹啉基配体：合成、表征和细胞毒性性质。
Molecules. 2024 Jul 6;29(13):3215. doi: 10.3390/molecules29133215.
6
The synthesis and antiparasitic activity of aryl- and ferrocenyl-derived thiosemicarbazone ruthenium(II)-arene complexes.芳基和二茂铁衍生的硫代半卡巴腙钌(II)-芳族配合物的合成及抗寄生虫活性。
Dalton Trans. 2013 Apr 7;42(13):4677-85. doi: 10.1039/c3dt32740j.
7
Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.钌（II）芳烃配合物稳定的硒醌：合成、结构与细胞毒性
Chemistry. 2014 May 5;20(19):5795-801. doi: 10.1002/chem.201304991. Epub 2014 Mar 26.
8
Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.发现含5,7-二卤代-2-甲基-8-喹啉醇的有机金属钌（II）-芳烃配合物具有高体外和体内抗肿瘤活性。
Dalton Trans. 2019 Apr 16;48(16):5352-5360. doi: 10.1039/c9dt00866g.
9
Evaluation of biomolecular interactions and cytotoxic activity of organometallic binuclear Ru(II) complexes of ferrocenyl thiosemicarbazones.评估二茂铁基硫代缩氨基脲的双金属有机双核 Ru(II) 配合物的生物分子相互作用和细胞毒性活性。
J Biomol Struct Dyn. 2021 Oct;39(16):6044-6055. doi: 10.1080/07391102.2020.1798284. Epub 2020 Jul 30.
10
Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.甾烷双齿配体的金属有机 Ru(II)、Rh(III) 和 Re(I) 配合物：合成、溶液形态、与生物分子相互作用和抗癌活性。
Dalton Trans. 2024 Mar 12;53(11):4984-5000. doi: 10.1039/d3dt04138g.
引用本文的文献
1
Anticancer potential of benzo[b]thiophene functionalized thiosemicarbazone ligands and their organoruthenium complexes.苯并[b]噻吩官能化硫代氨基脲配体及其有机钌配合物的抗癌潜力
J Biol Inorg Chem. 2025 Feb;30(1):71-85. doi: 10.1007/s00775-024-02090-w. Epub 2024 Dec 31.
2
Research Progress on the Biological Activities of Metal Complexes Bearing Polycyclic Aromatic Hydrazones.含多环芳香腙的金属配合物生物活性研究进展。
Molecules. 2022 Dec 1;27(23):8393. doi: 10.3390/molecules27238393.
3
Half-Sandwich Arene Ruthenium(II) Thiosemicarbazone Complexes: Evaluation of Anticancer Effect on Primary and Metastatic Ovarian Cancer Cell Lines.半夹心芳烃钌（II）硫代氨基脲配合物：对原发性和转移性卵巢癌细胞系抗癌作用的评估
Front Pharmacol. 2022 May 10;13:882756. doi: 10.3389/fphar.2022.882756. eCollection 2022.
4
Synthesis, cytotoxicity and docking studies (with SARS-CoV-2) of water-soluble binuclear Ru--cymene complex holding indole thiosemicarbazone ligand.含吲哚硫代半卡巴腙配体的水溶性双核钌-对异丙基苯配合物的合成、细胞毒性及（与新冠病毒的）对接研究
Inorg Chem Commun. 2021 Dec;134:109029. doi: 10.1016/j.inoche.2021.109029. Epub 2021 Oct 28.
5
A New Photoactivatable Ruthenium(II) Complex with an Asymmetric Bis-Thiocarbohydrazone: Chemical and Biological Investigations.一种新型光活化钌（II）配合物，具有不对称双硫代卡巴肼：化学和生物学研究。
Molecules. 2021 Feb 10;26(4):939. doi: 10.3390/molecules26040939.
6
Design, Synthesis, DNA/HSA Binding, and Cytotoxic Activity of Half-Sandwich Ru(II)-Arene Complexes Containing Triarylamine-Thiosemicarbazone Hybrids.含三芳基胺-硫代半卡巴腙杂化物的半夹心钌（II）-芳烃配合物的设计、合成、DNA/人血清白蛋白结合及细胞毒性活性
ACS Omega. 2019 Jul 5;4(7):11712-11723. doi: 10.1021/acsomega.9b01022. eCollection 2019 Jul 31.
7
Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity.半夹心型芳烃钌（II）和锇（II）硫代半卡巴腙配合物：溶液行为及抗增殖活性
Organometallics. 2018 Mar 26;37(6):891-899. doi: 10.1021/acs.organomet.7b00875. Epub 2018 Feb 20.
8
Cytotoxic gallium complexes containing thiosemicarbazones derived from 9-anthraldehyde: Molecular docking with biomolecules.含有源自9-蒽醛的硫代氨基脲的细胞毒性镓配合物：与生物分子的分子对接
J Mol Struct. 2016 Oct 5;1121:156-166. doi: 10.1016/j.molstruc.2016.05.075. Epub 2016 May 24.
9
Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.含噻唑烷酮的钌-芳配合物的半夹心配合物：[(η⁶-p-枯茗烯)Ru(胡椒醛缩噻唑烷酮)Cl]Cl 配合物的合成与生物评价。
J Inorg Biochem. 2011 Aug;105(8):1019-29. doi: 10.1016/j.jinorgbio.2011.04.008.
10
Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin.[(η(6)-p-cymene)Ru(2-蒽-9-亚甲基-N-乙基腙硫代甲酰胺)Cl]Cl 的合成与结构；生物评价、拓扑异构酶 II 抑制作用以及与 DNA 和人血清白蛋白的反应。
Metallomics. 2011 May 1;3(5):491-502. doi: 10.1039/c1mt00003a. Epub 2011 Feb 23.
本文引用的文献
1
Studies on the interaction of copper complexes of (-)-epicatechin gallate and (-)-epigallocatechin gallate with calf thymus DNA.（-）-表儿茶素没食子酸酯和（-）-表没食子儿茶素没食子酸酯的铜配合物与小牛胸腺DNA相互作用的研究。
J Inorg Biochem. 2008 Sep;102(9):1711-8. doi: 10.1016/j.jinorgbio.2008.04.008. Epub 2008 May 6.
2
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.NAMI-A型配合物(HL)[反式-四氯钌(III)L(S-二甲基亚砜)]（L =咪唑、吲唑、1,2,4-三唑、4-氨基-1,2,4-三唑和1-甲基-1,2,4-三唑）的构效关系：水合作用、氧化还原性质、蛋白质结合及抗增殖活性
J Med Chem. 2007 May 3;50(9):2185-93. doi: 10.1021/jm061081y. Epub 2007 Apr 3.
3
From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).从实验室到临床——抗癌药物反式-[四氯双(1H-吲唑)钌(III)] 吲哚鎓盐（KP1019或FFC14A）的临床前及早期临床开发
J Inorg Biochem. 2006 May;100(5-6):891-904. doi: 10.1016/j.jinorgbio.2006.02.013. Epub 2006 Feb 28.
4
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.新型钌（II）基有机金属化合物在非小细胞肺癌模型中的抗肿瘤活性及毒性特征
Biochem Pharmacol. 2006 Feb 14;71(4):408-15. doi: 10.1016/j.bcp.2005.10.053. Epub 2005 Dec 19.
5
Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity.单功能钌（II）芳烃配合物修饰的DNA构象：DNA结合蛋白的识别与修复。与细胞毒性的关系。
Chem Biol. 2005 Jan;12(1):121-9. doi: 10.1016/j.chembiol.2004.11.008.
6
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.钌（III）的杂环配合物可诱导结肠癌细胞凋亡。
J Cancer Res Clin Oncol. 2005 Feb;131(2):101-10. doi: 10.1007/s00432-004-0617-0. Epub 2004 Oct 16.
7
A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.一项关于新型钌抗癌药物咪唑鎓-反式二甲基亚砜-咪唑-四氯钌酸盐的I期药理学研究。
Clin Cancer Res. 2004 Jun 1;10(11):3717-27. doi: 10.1158/1078-0432.CCR-03-0746.
8
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.单功能有机金属钌（II）抗肿瘤复合物在无细胞培养基中的DNA相互作用
Biochemistry. 2003 Oct 7;42(39):11544-54. doi: 10.1021/bi034933u.
9
Ovarian cancer: strategies for overcoming resistance to chemotherapy.卵巢癌：克服化疗耐药性的策略
Nat Rev Cancer. 2003 Jul;3(7):502-16. doi: 10.1038/nrc1123.
10
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.顺铂作用机制的生化调节：增强抗肿瘤活性并规避耐药性。
Chem Rev. 2003 Mar;103(3):645-62. doi: 10.1021/cr020010d.
Zotero 插件